Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VEGFD Protein (AA 89-205, full length) (GST tag)

Figf Origin: Human Host: Escherichia coli (E. coli) Recombinant 90 % ELISA
Catalog No. ABIN1047904
  • Target See all VEGFD (Figf) Proteins
    VEGFD (Figf) (C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D) (Figf))
    Protein Type
    Recombinant
    Protein Characteristics
    AA 89-205, full length
    Origin
    • 9
    • 3
    • 3
    • 2
    Human
    Source
    • 6
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    Escherichia coli (E. coli)
    Purification tag / Conjugate
    This VEGFD protein is labelled with GST tag.
    Application
    ELISA
    Sequence
    FAATFYDIET LKVIDEEWQR TQCSPRETCV EVASELGKST NTFFKPPCVN VFRCGGCCNE ESLICMNTST SYISKQLFEI SVPLTSVPEL VPVKVANHTG CKCLPTAPRH PYSIIRR
    Characteristics
    Please inquire if you are interested in this recombinant protein expressed in E. coli, mammalien cells or by baculovirus infection. Be aware about differences in price and lead time.
    Purity
    90 %
    Top Product
    Discover our top product Figf Protein
  • Comment

    The yeast protein expression system is the most economical and efficient eukaryotic system for secretion and intracellular expression. A protein expressed by the mammalian cell system is of very high-quality and close to the natural protein. But the low expression level, the high cost of medium and the culture conditions restrict the promotion of mammalian cell expression systems. The yeast protein expression system serve as a eukaryotic system integrate the advantages of the mammalian cell expression system. A protein expressed by yeast system could be modificated such as glycosylation, acylation, phosphorylation and so on to ensure the native protein conformation. It can be used to produce protein material with high added value that is very close to the natural protein. Our proteins produced by yeast expression system has been used as raw materials for downstream preparation of monoclonal antibodies.

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    0.2-2 mg/mL
    Buffer
    Tris-based buffer, 50 % glycerol
    Handling Advice
    Repeated freezing and thawing is not recommended. Store working aliquots at 4 °C for up to one week
    Storage
    -20 °C
    Storage Comment
    Store at -20 °C for extended storage, conserve at -20 °C or -80 °C
  • Ota, Suzuki, Nishikawa, Otsuki, Sugiyama, Irie, Wakamatsu, Hayashi, Sato, Nagai, Kimura, Makita, Sekine, Obayashi, Nishi, Shibahara, Tanaka, Ishii, Yamamoto, Saito, Kawai, Isono, Nakamura, Nagahari et al.: "Complete sequencing and characterization of 21,243 full-length human cDNAs. ..." in: Nature genetics, Vol. 36, Issue 1, pp. 40-5, (2003) (PubMed).

    Rocchigiani, Lestingi, Luddi, Orlandini, Franco, Rossi, Ballabio, Zuffardi, Oliviero: "Human FIGF: cloning, gene structure, and mapping to chromosome Xp22.1 between the PIGA and the GRPR genes." in: Genomics, Vol. 47, Issue 2, pp. 207-16, (1998) (PubMed).

    Achen, Jeltsch, Kukk, Mäkinen, Vitali, Wilks, Alitalo, Stacker: "Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 95, Issue 2, pp. 548-53, (1998) (PubMed).

    Yamada, Nezu, Shimane, Hirata: "Molecular cloning of a novel vascular endothelial growth factor, VEGF-D." in: Genomics, Vol. 42, Issue 3, pp. 483-8, (1997) (PubMed).

  • Target
    VEGFD (Figf) (C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D) (Figf))
    Alternative Name
    Vascular endothelial growth factor D protein (Figf Products)
    Background
    Growth factor active in angiogenesis, lymphangiogenesis and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors.
    Molecular Weight
    40.5 kD
    UniProt
    O43915
    Pathways
    RTK Signaling
You are here:
Support